Neoleukin Therapeutics
Why Robinhood?
You can watch NLTX and buy or sell other stocks, ETFs, and their options commission-free!About NLTX
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NLTX Key Statistics
Stock Snapshot
Neoleukin Therapeutics(NLTX) stock is priced at $30.09, giving the company a market capitalization of 466.09M. It carries a P/E multiple of -4.59.
During the trading day, Neoleukin Therapeutics(NLTX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 112.3K.
The stock's 52-week range extends from a low of $8.05 to a high of $37.27.
The stock's 52-week range extends from a low of $8.05 to a high of $37.27.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.